UK Cancer Waiting Times Improve But Remain Below Targets in Key Measures
The latest NHS cancer performance data presents a mixed picture of improvement in some measures alongside persistent shortfalls in others, reflecting both the genuine progress being made through investment in diagnostic capacity and the continuing challenge of translating earlier diagnosis into timely treatment when referral pathways, specialist surgical capacity and oncology staffing remain under pressure.
The 28-day Faster Diagnosis Standard, which measures the time from urgent GP referral to a patient receiving either a definitive cancer diagnosis or a clear ruling that cancer is not present, stood at 77.5 percent in April 2026 — exceeding the 75 percent target for the third consecutive month and representing one of the clearer success stories in the NHS cancer programme. The improvement reflects significant investment in community diagnostic centres, endoscopy capacity and the rollout of artificial intelligence-assisted image interpretation in radiology.
The 62-day standard — measuring time from urgent referral to treatment commencement — told a less positive story. Performance stood at 72.5 percent against an 85 percent target, a gap that translates into thousands of patients per month experiencing waits longer than the clinically recommended maximum. The failure to meet this target, which has persisted for several years, reflects the complexity of the treatment pathway after diagnosis: surgical capacity, radiotherapy appointment availability, drug supply chain reliability and multi-disciplinary team meeting schedules all contribute to delays that begin after the diagnostic process concludes.
Macmillan Cancer Support called for targeted investment in the surgical workforce and radiotherapy estate, noting that the bottleneck in treatment capacity was a different problem from the diagnostic capacity issue that the community diagnostic centre programme had addressed. Without equivalent investment in treatment capacity, improvements in diagnosis speed would not translate fully into improved patient outcomes.
